Skip to Content

Medtronic PLC Cedear MDT

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MDT is trading within a range we consider fairly valued.
Price
ARS 23,844.98
Fair Value
ARS 51,686.34
Uncertainty
High
1-Star Price
ARS 52,563.69
5-Star Price
ARS 77,938.36
Economic Moat
Sxcqr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDT is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
9.10
Price/Sales
1.40
Dividend Yield (Trailing)
1.67%
Dividend Yield (Forward)
2,180.74%
Total Yield
1.77%

Company Profile

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
95,000

Competitors

Valuation

Metric
MDT
BSX
ABT
Price/Earnings (Normalized)
9.1034.8823.89
Price/Book Value
0.375.514.70
Price/Sales
1.407.474.55
Price/Cash Flow
6.2031.7118.35
Price/Earnings
MDT
BSX
ABT

Financial Strength

Metric
MDT
BSX
ABT
Quick Ratio
1.460.941.16
Current Ratio
2.301.661.64
Interest Coverage
8.868.8810.86
Quick Ratio
MDT
BSX
ABT

Profitability

Metric
MDT
BSX
ABT
Return on Assets (Normalized)
7.75%9.16%10.63%
Return on Equity (Normalized)
13.75%16.77%20.87%
Return on Invested Capital (Normalized)
9.87%11.67%14.81%
Return on Assets
MDT
BSX
ABT
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesVxrrvpysByvhw$181.1 Bil
SYK
Stryker CorpZpcsrxjswYqhj$127.5 Bil
MDT
Medtronic PLCCvvfdkgbNqbzggh$113.7 Bil
BSX
Boston Scientific CorpTsdjpldLnftqh$109.6 Bil
EW
Edwards Lifesciences CorpHsztcsgrBwdqh$54.3 Bil
DXCM
DexCom IncSndsldxjhqNywqh$52.0 Bil
PHG
Koninklijke Philips NV ADRQvtqjmqcMxpsjrp$26.4 Bil
ZBH
Zimmer Biomet Holdings IncSxtqtmqchXfbf$24.7 Bil
ALGN
Align Technology IncFyqlscyjZsxqcd$20.6 Bil
PODD
Insulet CorpZyrkjdzmsZssmctl$13.1 Bil

Sponsor Center